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Ankyrin repeat domain 17 (Ankrd17) encodes an ubiquitously expressed protein with two clusters of
ankyrin repeats. We have used gene targeting strategy to ablate the Ankrd17 gene in mouse. The
Ankrd17-deﬁcient mice died between embryonic day (E) 10.5 and E11.5 due to cardiovascular
defects. Serious hemorrhages were detected and the vascular smooth muscle cells (vSMCs) sur-
rounding the vessels were drastically reduced in the Ankrd17-deﬁcient embryos, suggesting that
the vascular maturation was not completed. Interestingly, vSMC differentiation marker genes were
up-regulated in the mutant embryos. Our data have demonstrated the indispensability of Ankrd17
functioning for vascular maturation during early development. The Ankrd17-deﬁcient mice also
provide a new animal model for the analysis of the regulatory pathways of the differentiation of
vSMC precursor cells.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The vascular system is the ﬁrst functional organ system devel-
oped in vertebrate embryogenesis. Following vasculogenesis and
angiogenesis is the maturational step, during which time the vas-
cular smooth muscle cells (vSMCs) are recruited to the primitive
vessel network in order to form the stable mature vessel walls
[1]. The vSMCs promote the survival, maturation, and stability of
the endothelial cells (ECs), synthesize the extracellular matrix,
and maintain the blood pressure through their contractile nature
[2,3]. vSMCs are characterized by the expression of a number of
differentiation marker genes such as the smooth muscle (SM) a-ac-
tin, SM22a, and SM-myosin heavy chain (SM-MHC) which produce
contractile proteins [4]. Targeted disruptions of several genes in-
volved in vSMC development resulted in the abnormal vessel mor-
phology, leakage of the vasculature, and lethality of the early
embryos [5]. The origin of vSMCs has been intensively investigated.
vSMCs in different regions of the vascular system are derived from
different cell lineages. For example, vSMCs in the trunk area are de-chemical Societies. Published by E
.-K.J. Shen).
.J. Shen), yyan@ibms.sinica.rived from paraxial mesoderm (somite) [6,7] and from the splanch-
nic lateral plate mesoderm [8]. In the cephalic region and the
cardiac outﬂow tract, on the other hand, the vSMCs arise from
the neural crest cells (NCs) [9,10].
Like vasculogenesis and angiogenesis, the process of vSMC
recruitment is also controlled by ligand-receptor pathways such
as those involving the transforming growth factor b1 (TGF-b1),
platelet-derived growth factor BB (PDGF-BB), Notch, and others.
Among theses factors, TGF-b1 serves as an inducer for vSMC differ-
entiation and its marker genes. PDGF-BB secreted by ECs is an
antagonist of TGF-b1 and it stimulates the migration of vSMCs or
their progenitors, the latter of which includes the mesenchymal
cells [11,12]. Finally, Notch promotes vSMC differentiation upon
the attachment of vSMCs to the ECs [13–15]. Of particular interest,
PDGF-BB also induces the phenotype switch of vSMCs during dis-
eases or vascular injury [3]. In the latter process, vSMCs switch
from differentiated (contractile) state into dedifferentiated (syn-
thetic) state. These synthetic vSMCs are proliferative, migrative,
and are characterized by down regulation of the differentiation
marker genes including SM a-actin, SM22a, and SM-MHC
[4,16,17]. Recently, the repression mechanism of vSMC differentia-
tion marker genes has been intensive investigated. Several tran-
scriptional repressors such as KLF4, phosphorylated Elk-1, and
HERP1 were reported to act downstream of PDGF-BB [18].lsevier B.V. All rights reserved.
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mouse gene encoding a 260 kDa protein composed of two do-
mains of ankyrin repeats and one KH domain (Fig. 1B) [19]. The
gene has been reported to have two promoters, one of which is
restrictively activated in the liver lineage and the other drives
the Ankrd17 expression ubiquitously [19]. The biological function
of Ankrd17 has been unknown. In this study, we have used mouse
gene targeting technology to show that Ankrd17 may regulate the
differentiation of vSMC precursors and consequently their recruit-
ment to the vessel tubes during early embryonic development.
2. Materials and methods
2.1. Materials
Ankrd17 antiserum was generated in rabbit immunized with a
peptide corresponding to the region from aa 1425 to 1596 of
Ankrd17. Anti-CD31 (PECAM-1), anti-SM a-actin, and anti-VWF
(von Willebrand Factor) antibodies were purchased from BD Bio-
Sciences, Sigma–Aldrich, and Millipore, respectively.
2.2. Gene targeting and genotyping
The removal of exon 8 of Ankrd17 gene was achieved by
standard gene-targeting approach using the Cre-lox recombination
system. Genotyping of the mutant mice, Ankrd17+/DE8 andFig. 1. Targeted disruption of the mouse Ankrd17 gene. (A) Targeting strategy. Exon 8 corr
exon 8 and the ﬂoxed neo cassette. Subsequently, the neo cassette and exon8 were remo
of the wild-type Ankrd17 protein and the 455 aa truncated protein, as the result of exon
and mutant embryos. Xba I digested genomic DNAs were used for analysis. A 7.7 kb frag
exon 8 deletion in the deletion allele by PCR using a primer pair ﬂanking exon 8. The wAnkrd17DE8/DE8 (labeled in the text as Ankrd17+/D and Ankrd17D/D,
respectively), also followed standard methods. For more details,
see text and Supplementary materials and methods.
2.3. Whole-mount in situ hybridization
Embryos of different stages were dissected and ﬁxed in 4% PFA
at 4 C overnight. The in situ hybridization procedure was per-
formed as described previously [20]. A fragment corresponding
to nt 5462 to nt 6042 of the Ankrd17 cDNA was generated by
RT-PCR and cloned into T Vector (Promega, Madison, WI). The
sense and antisense RNA probes were then generated using the
Roche DIG RNA Labeling Kit (SP6/T7) (Roche, Palo Alto, CA).2.4. Histology and immunoﬂuorescence staining
The embryos were dissected, ﬁxed, wax embedded, sectioned in
a thickness of 5 lm, and subjected to immunoﬂuorescence staining
as described in Supplementary materials and methods.2.5. Whole-mount immunostaining
The whole-mount immunostaining of the embryos ﬁxed in 4%
PFA at 4 C overnight was carried out as detailed in Supplementary
materials and methods.esponding to the ankyrin domain 1 (ANK1) of Ankrd17 was replaced with the ﬂoxed
ved by germline expression of the cre recombinase (EIIa-cre mice). (B) Physical map
8 deletion (see text for more details). (C) Southern blotting analysis of the wild-type
ment (T) was generated from the targeted allele (‘‘” in A). (D) The conﬁrmation of
ild-type (WT) and the exon 8 deletion (DE8) bands are indicated.
Fig. 2. Comparative expression patterns of Ankrd17 in wild-type and mutant
embryos. (A-a) Western blot analysis of total lysates from the wild-type and
Ankrd17D/D embryos. Note the lack of full-length Ankrd17 proteins as seen in the
wild-type. (A-b) Northern blot analysis of total RNAs from embryos using a probe
spanning E5–E11 of the Ankrd17 cDNA. Note the reduction of the RNA level in the
mutants. (A-c) qRT-PCR analysis. Note that use of a primer pair from exon 8 showed
the absence of exon 8 in the total RNA of the Ankrd17D/D embryos. The error bars
show the standard deviations (SD). (B) Whole-mount in situ hybridization analysis
of Ankrd17 mRNA in E9.5 wild-type and Ankrd17D/D embryos with RNA probes from
exon 8 (a) and exon 29 (b) of Ankrd17. Bar = 1 mm.
Table 1
Embryo lethality of Ankrd17 mutant embryos.
Age No. (%) of animals Total
D/D +/ +/+
E8.5 5 (28) 10 (55) 3 (17) 18
E9.5 67 (28) 107 (45) 66 (27) 240
E10.5 127 (26) 229 (46) 142 (28) 498
E11.5 16a (27.5) 26 (45) 16 (27.5) 58
E12.5–16.5 0 (0) 60 (76) 19 (24) 79
Postnatal 0 (0) 186 (68) 85 (32) 271
E, Embryonic day.
a Absorbed embryos.
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E10.5 embryos were dissected in PBS and immediately injected
with 20% India ink diluted in PBS–Tween 20 (0.1%) using a micro-
capillary and a mouth pipette [21]. Images were acquired immedi-
ately following the ink injection using the Nikon SMZ1500
microscope with SPOT Flex imaging system.
2.7. Northern blot analysis, reverse transcription (RT), and
quantitative RT-PCR (qRT-PCR)
Total RNAs from the wild-type and mutant embryos were iso-
lated and subjected to Northern blot analysis as detailed in Supple-
mentary materials and methods. After treatment with 10 units
DNase I (Roche Applied Science) for 1 h, 1 lg of the RNA was re-
versed transcribed using SuperScript II reverse transcriptase (Invit-rogen) with oligo(dT) primers in a total volume of 20 ll. qRT-PCR
was performed using SYBR Green and carried out on a LightCycler
qRT-PCR machine (Roche Molecular Biochemicals version 1.2).
Primers are listed in Table 2. For more details, see Supplementary
materials and methods.
2.8. Western blot analysis
Western blotting was carried out following standard protocols.
Dissected embryos were homogenized and lysed in RIPA buffer.
Ten micrograms of total protein were electrophoresed on a 8% so-
dium dodecyl sulfate–polyacrylamide gel and then electrotrans-
ferred to a nitrocellulose membrane (Amersham Biosciences).
The blots were ﬁrst incubated with the primary antibodies, and
then with secondary antibodies prepared in Tris–buffered saline
solution containing 5% non-fat dry milk. The labeled bands were
identiﬁed using an enhanced chemiluminescence (ECL) detection
system (Amersham Biosciences).
3. Results and discussion
3.1. Generation of Ankrd17-deﬁcient mice
Ankrd17 was initially identiﬁed in a gene trap screening in
embryonic stem cells [22]. The homozygous mice of one of the
gene trapped lines, I114, were viable and fertile, likely due to inef-
fective blockage of the Ankrd17 gene transcription. To investigate
the biological role of Ankrd17 in vivo, we generated Ankrd17-deﬁ-
cient mice by the gene targeting approach (see Fig. 1A and Section
2 for more details). In particular, we deleted exon 8 of Ankrd17
resulting in a frame shift of the remaining Ankrd17 transcript thus
generating a stop codon at nt 45 of exon 9, i.e. nt 1363 of the
Ankrd17 cDNA (Fig. 1B). The generations of the targeted allele
(‘‘” in Fig. 1A) and exon-deletion allele (‘‘D” in Fig. 1A) were val-
idated by Southern blotting (Fig. 1C) and PCR (Fig. 1D) analysis,
respectively, of the genomic DNAs.
Western blotting as probed by an anti-Ankrd17 antibody
against aa 1425–1596 showed that the expression of Ankrd17 pro-
tein was abolished in the homozygous embryos (Fig. 2A-a). Inter-
estingly, the Ankrd17 mRNA level from the homozygous
Ankrd17D/D mutant embryos was also signiﬁcantly decreased, as
evidenced by both Northern blotting (Fig. 2A-b) and quantitative
RT-PCR (qRT-PCR) using a pair of primers from exons 23–24
(Fig. 2A-c). These observations suggested that deletion of exon 8
not only resulted in the frame shift but might also affect the
Ankrd17 mRNA stability. The lack of Ankrd17 expression in the
homozygous mutant embryos correlated well with our data from
the whole-mount in situ hybridization analysis. As seen, except
for the heart area, Ankrd17 was expressed throughout the wild-
type embryos at E9.5, but not in the mutant embryos probed by
the exon 8 probe (Fig. 2B-a). Consistent with the Northern blot re-
Fig. 3. Embryonic lethality and severe hemorrhages of E10.5 Ankrd17D/D. (A-a and
A-b) Morphology analysis showing the pale appearance of the yolk sac of E10.5
Ankrd17D/D embryo (A-b), likely due to poor blood circulation, in comparison to that
of the wild-type (A-a). The arrows in A-a indicate the vessels. (A-c and A-d)
Morphology analysis showing the retarded growth, enlarged pericardium, and
hemorrhage of the mutant embryo (A-d) when compared with the wild-type (A-c).
H, heart. The arrows indicate the pericardium, and the arrow head in A-d indicates
an area with hemorrhage. Bar: 1 mm. (B-a and B-b) Leakage of the cranial vessel (V)
was detectable in histological horizontal sections of the E10.5 Ankrd17D/D embryos
(B-b) but not in wild-type (B-a). (B-c and B-d) Histological sections revealing the
heart morphologies of the wild-type (B-c) and E10.5 Ankrd17D/D embryos (B-d).
Note the presence of blood cells in the enlarged pericardium space of the mutant
embryo (arrow in B-d). RA, right atrium; LA, left atrium; LV, left ventricle.
Bar = 50 lm. (C-a and C-b) Ink injection analysis showing the leakage of the ink out
of the vessels in Ankrd17D/D embryo (the red arrow, C-b) but not in the wild-type
(C-a). Bar = 1 mm.
Table 2
Primer sequences for qRT-PCR.
Gene Direction Sequence
Ankrd17 exon 8 F 5-GCTGATTCATTTGAGTCACCA-3
R 5-CATTTCTTCATGTCCTTCACGAG-3
Ankrd17 exons 23–24 F 5-CAGGAGGTGGTGGAGTT-3
R 5-CAGTGGAGAAATGCCCAA-3
Vegf F 5-CATAGAGAGAATGAGCTTCCTACAGC-3
R 5-TGCTTTCTCCGCTCTGAACAAGG-3
Fgf2 F 5-GTCACGGAAATACTCCAGTTGGT-3
R 5-CCCGTTTTGGATCCGAGTTT-3
Dll4 F 5-AGCTGGGTGTCTGAGTAGGC-3
R 5-AGAAGGTGCCACTTCGGTTA-3
Cd31 F 5-GAGCCCAATCACGTTTCAGTTT-3
R 5-TCCTTCCTGCTTCTTGCTAGCT-3
Integrin-aV F 5-GTTTGATTCAACAGGCAATCGAG-3
R 5-CAGGCCAAGATTTTATCCTGCTT-3
Ephrin-B2 F 5-GGAGGGCCTGGATAACC-3
R 5-TGGCTTCACAAAGGGACT-3
Pten F 5-AAAGGGACGGACTGGTGTAA-3
R 5-CCTCTGACTGGGAATTGTGA-3
Id1 F 5-CATGAACGGCTGCTACTCAC-3
R 5-GTGGTCCCGACTTCAGACTC-3
SM a-actin F 5-GAACGCTTCCGCTGCCC-3
R 5-GGATGCCCGCTGACTCC-3
SM22a F 5-CTCTAATGGCTTTGGGCAGTTTG-3
R 5-TGCAGTTGGCTGTCTGTGAAGTC-3
SM-MHC F 5-CATGGACCCGCTAAATGACA-3
R 5-CAATGCGGTCCACATCCTTC-3
Myocardin F 5-CAAACTGGTGTTTCTTCTCTCAAACC-3
R 5-TCGAAGCTGTTGTCTTAACTCTGA-C-3
Klf4 F 5-ACCTACCCTCCTTTCCTGCC-3
R 5-AATTTCCACCCACAGCCGTC-3
Tgf-b1 F 5-GCAACATGTGGAACTCTACCAGAA-3
R 5-GACGTCAAAAGACAGCCACTCA-3
Pdgf-B F 5-TGTTCCAGATCTCGCGGAAC-3
R 5-GCGGCCACACCAGGAAG-3
Tie2 F 5-GACGATTTACAAACAGCGTCTATCGG-3
R 5-GGGAGAATGTCACTAAGGGTCCAG-3
18S F 5-TTGACGGAAGGGCACCACCAG-3
R 5-GCACCACCACCCACGGAATCG-3
F, Forward; R, reverse.
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the mutant embryos (Fig. 2B-b). The data of Figs. 1 and 2 together
demonstrated that expression of the multiple isoforms of the
Ankrd17 protein was abolished and the mRNA expression was
greatly decreased in the Ankrd17D/D mice with homozygous exon
8-deletion of their Ankrd17 genes.
3.2. Early embryonic lethality of the Ankrd17D/D embryos with severe
hemorrhages
The heterozygous Ankrd17+/D mice were viable and fertile, and
they showed no phenotypic abnormalities when compared to the
wild-type (Ankrd17+/+) littermates. However, the homozygosity of
the Ankrd17 mutation resulted in embryonic lethality, with no
homozygous mutant embryos beyond E11.5 (Table 1). Before
E11.5, the Ankrd17 homozygotes were recovered in the expected
Mendelian ratio (Table 1). At E9.5, the Ankrd17D/D embryos were
generally indistinguishable from those of the wild-type littermates
(data not shown). Remarkably, like several gene-targeted mutants
with cardiovascular failures, e.g. those with mutations in Notch1
[23], Hey1/Hey2 [24], Ephrin-B2 [25], Tie2 [26], the homozygousAnkrd17D/D embryos at E10.5–E11 also exhibited obvious pheno-
types including a pale yolk sac (compare Fig. 3A-b to A-a), growth
retardation (compare Fig. 3A-d to A-c), and enlarged pericardial sac
(Fig. 3A-d). Furthermore, hemorrhages appeared in the head re-
gions, the pericardial cavities and ventral parts of the trunk
(Fig. 3A-d and data not shown). However, while the circulation
Fig. 4. Whole-mount immunostaining patterns of embryos with use of anti-CD31.
CD31 antibody was used for whole-mount analysis of the wild-type (A, C, E, and G)
and Ankrd17-deﬁcient embryos (B, D, F, and H). The pattern of the E10.5 yolk sacs (A
and B) and embryos (C–H) are shown. The vascular network in the wild-type (A) can
also be seen in the Ankrd17D/D yolk sac (B). The cranial vessels also appear in both
the wild-type (C) and mutant (D) embryos. (E and F) The angiogenetic sprouts of the
intersomitic vessels are present in both types of embryos (E and F), but the vascular
pattern in the mutant trunk (F) is less organized. Bar = 1 mm. (G and H) Magniﬁed
pictures of the regions boxed in E and F, respectively.
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Ankrd17D/D embryos remained beating (data not shown), suggest-
ing that the conduction system was unaffected. Therefore, hemor-
rhages of the vascular system emerged as a main factor in the
embryonic lethality of the homozygous Ankrd17D/D embryos.
Histological sections of the E10.5 Ankrd17D/D embryos showed
blood cells extravasated from the cranial vessels (compare Fig. 3B-
a and B-b). This was consistent with observations under the stereo
microscope (Fig. 3A-d). Besides, blood accumulation in the pericar-
dium space was detected (compare Fig. 3B-d to B-c), indicating that
the blood vessel integrity was compromised. In Fig. 3B-c, increasing
trabeculation and closure of the atrioventricular canal were de-
tected in the progressively developing heart in the wild-type em-
bryos. In contrast, the Ankrd17D/D embryos showed arrest of the
endocardiumdevelopment, thinnermyocardium, andpoor trabecu-
laration in the ventricle (Fig. 3B-d). These defects could be due to a
secondary effect of the lack of the circulating blood or the global
developmental delay. Furthermore, the neural tube was thinner
and the mesenchymal compartment less condensed (compare
Fig. 3B-b and B-d to B-a and B-c, respectively). The integrity of the
vascular networkwas further examinedby injection of India ink into
the beating hearts of E10.5 embryos. As expected, the ink traveled
through the branchial arteries, dorsal aorta and intercarotid artery
to the trunk and head areas in both the wild-type and Ankrd17D/D
embryos (Fig. 3C). However, in the Ankrd17D/D embryos, the ink
leaked out of the vessels (compare Fig. 3C-b to C-a), indicating the
instability of the vessels of the mutant embryos.
3.3. Dispensability of Ankrd17 for vasculogenesis
To investigate the cellular basis of the apparent vascular defects
in the Ankrd17D/D embryos, we ﬁrst performed whole-mount
immunostaining using anti-CD31 (PECAM-1) antibody as the
probe, which recognized the endothelial cells (Fig. 4). As seen,
the vasculature morphologies of the Ankrd17D/D yolk sacs and em-
bryos were similar to those of the wild-type littermates (compare
Fig. 4A and B), with no obvious abnormalities in the branchial
arteries, dorsal aortas, intercarotid arteries, cardinal veins, interso-
mitic vessels, and small capillaries. Neither there was any vascular
malformation, such as the arteriovenous shunt, detected (compare
Fig. 4C and E to D and F, respectively). However, the diameter of
the vessels was less regular and the capillary network in the somite
area of Ankrd17D/D embryos was less organized than the wild-type
(compare Fig. 4E and G to F and H, respectively).
3.4. Altered gene expression patterns and vascular instability of the
Ankrd17D/D embryos
In view of the above, we then used qRT-PCR to examine the
expression of genes involved in vascular development (Fig. 5A).
Interestingly, the mRNA level of VEGF (vascular endothelial growth
factor), an essential factor for blood vessel formation and homeo-
stasis, was greatly up-regulated in the Ankrd17D/D embryos. On
the other hand, the gene-targeted mutation did not affect the
expression levels of other genes known to be involved in vasculo-
genesis or angiogenesis, which included FGF, Id1 and Integrin aV
important for the formation and migration of the endothelial cells;
Dll4, Hey2, and EphrinB2 for the arterial-cell fate determination;
Ang1 and Tie2 for the stability of the vessel tubes (Fig. 5A). The
high expression of VEGF very likely resulted from hypoxia caused
by the loss of normal circulation, as previously observed in Notch1-
as well as Hey1/Hey2-double-knockout mice [24].
We suspected that disruption of the blood circulation system
including the massive hemorrhages might result from the instabil-
ity of the blood vessels. Furthermore, it was known that the integ-
rity and stability of vessels are ensured by the coverage withvSMCs. To see if the apparent disruption of the vascular integrity
in the Ankrd17D/D embryos might be due to defects in their vSMCs,
we carried out immunoﬂuorescence staining of the embryos with
use of anti-SM a-actin antibody. As observed on E10.5 cross-sec-
tions, the SM a-actin staining was much stronger surrounding
the dorsal aorta of the wild-type embryos than that of the
Ankrd17D/D embryos (compare Fig. 5C-a and C-b). Immunostaining
using an antibody against SM22a, another vSMCmarker, gave sim-
ilar results (data not shown). The apparent diminishment of vSMCs
surrounding the vessels of the mutant embryos, as exempliﬁed in
Fig. 5C-b, was not due to the lack of expression of vSMC differenti-
ation-induction factors TGF-b1 and myocardin; Ang1 and Tie2
important for the vSMC/EC contact; or the vSMC chemo-attractor
PDGF-BB. As seen in Fig. 5B-a, these genes of the mutant embryos
were all expressed at similar levels as the wild-type. However, in
interesting contrast to the diminished SM a-actin staining sur-
rounding the vessels (Fig. 5C-b), the transcripts of the SM a-actin
Fig. 6. Defective vSMC coverage on the vessels of the mutant embryos. Whole-
mount immunoﬂuorescence double-staining of CD31 and SM a-actin in E10.5
embryos was carried out. Note that the SM a-actin signal was restricted on the
surface of the intercarotid artery of the wild-type embryos (A). In contrast, the
signal was detected widely in the head area of the Ankrd17D/D embryos and poorly
co-localized with the CD31 signals (B). The arrows indicate the intercarotid arteries.
Bar = 100 lm.
Fig. 5. Alteration of gene expression and reduced vSMCs around the vessels in the mutant embryos. (A) qRT-PCR analysis of genes involved in vasculogenesis and
angiogenesis. The mRNA levels of Vegf, Fgf2, Dll4, Cd31, Integrin-aV, Ephrin-B2, Pten, and Id1 genes in the wild-type and Ankrd17D/D embryos were compared by qRT-PCR.
Three each of the wild-type and mutant embryos were used for the analysis. (B-a) qRT-PCR analysis of the expression levels of SM a-actin, SM22a, SM-MHC, Myocardin, KLF4,
Tgf-b1, Pdgf-B, Tie2, and Angtp1 in the wild-type (black bars) and mutant (gray bars) embryos. (B-b) Western blot analysis of total lysates showing up-regulation of the SM a-
actin and SM-MHC genes in the mutant embryos. Heat shock protein 70 (HSP70) was used as an internal control. (C) Immunoﬂuorescence staining patterns of SM a-actin and
VWF surrounding the vessels. Note the signiﬁcant reduction of the SM a-actin, but not VWF, an endothelial cell marker, signal in E10.5 Ankrd17D/D embryos (b), when
compared to the wild-type (a). Bar = 100 lm. (D) Whole-mount immunostaining of SM a-actin in E10.5 embryos. Note the stronger staining signal in the cranial (arrow) and
trunk region of the Ankrd17D/D embryos. The boxed areas in the trunk regions are further magniﬁed in the right panels. Bar = 1 mm.
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were both up-regulated in the Ankrd17D/D embryos (left two pairs
of bars, Fig. 5B-a). The up-regulation of the SM a-actin gene
expression in the mutant embryos was further conﬁrmed by Wes-
tern blotting (Fig. 5B-b) and by whole-mount immunostaining
(Fig. 5D). However, both in qRT-PCR (the third pair of bars from
the left, Fig. 5B-a) and Western (Fig. 5B-b) analysis, the expression
of the vSMC terminal differentiation marker gene, SM-MHC, was
identical between the mutant and wild-type embryos.
The higher expression level of the vSMC differentiation marker
gene, SM a-actin, could result from disruption of the repression
system that has been shown to be essential for vSMC migration
process during vessel formation and vessel injury [18]. In the ves-
sel maturation step, vSMCs precursors migrate from their originat-
ing sites to the EC tubes by PDGF-BB attraction [27]. Therefore, the
abnormally high expression of SM a-actin in the vSMC precursors
might block this migration process. Besides, the lateral plate meso-
derm-derived vSMCs on the ventral side of the aorta are replaced
on E10.5 by those derived from paraxial mesoderm [28]. It was
thus of special interest to note that the whole-mount immuno-
staining signal of SM a-actin in the somite, recently shown to be
a site of vSMC origin [6,7], was particularly stronger in Ankrd17D/
D embryos than the wild-type (Fig. 5D). In addition to the somite,
the signals in the craniofacial regions of the Ankrd17D/D embryos
were stronger than those in the wild-type (Fig. 5D). Although it
was still likely that Ankrd17 played a repression role of SM-MHC
expression, the apparently un-altered level of SM-MHC in Ankrd17
mutant embryos might be due to the relatively low expression of
SM-MHC at E10.5 [29].To further examine the vSMC coverage in the Ankrd17D/D em-
bryos, whole-mount immunoﬂuorescence double-staining of
CD31 and SM a-actin was performed. Unlike the restricted distri-
bution on the surface of the intercarotid artery of the wild-type
embryos (Fig. 6A), the SM a-actin signal exhibited a diffused and
mislocalized pattern in the mutant embryos (Fig. 6B). Furthermore,
while we could also observe vSMC coverage in the brachial arches,
we failed to detect SM a-actin signal in the brachial arches of both
S.-C. Hou et al. / FEBS Letters 583 (2009) 2765–2771 2771the wild-type and mutant embryos, possibly due to the early stage
of the embryos examined (data not shown). Taking the above to-
gether, we hypothesized that de-repression of the vSMC differenti-
ation marker genes, in particular SM a-actin, in the Ankrd17D/D
embryos may block the migration of induced vSMC precursors
from its originating site(s) to the immature endothelial tubes thus
reducing the numbers of vSMCs surrounding the vessels. However,
the present data are not sufﬁcient for us to rule out a possible role
of Ankrd17 in vSMC/EC contact. Tissue-speciﬁc knockout of
Ankrd17 expression is needed to address this issue.
In conclusion, through mouse gene targeting analysis, we have
identiﬁed the ankyrin repeat factor Ankrd17 as a novel regulator
for the formation and/or maintenance of the blood vessels of the
circulation system. Ankrd17 may participate in the repression of
the vSMC differentiation marker genes, and consequently ensure
the regulated migration of vSMC precursor cells from their origi-
nating sites to the vessels. The details of the regulatory mecha-
nisms of how Ankrd17 represses the SM a-actin gene expression,
possibly through functional as well as physical interactions with
factors known to be essential for the blood vessels maturation,
e.g. the KLF family of factors, remains to be fully elucidated. Finally,
whether Ankrd17 participates in one or more of the pathways in-
volved in vascular maturation, such as PDGF/PDGFR, TGF-b1/
ALK1/endoglin, ANG1/TIE2, JAG1/NOTCH, and S1P/S1P1 [14,30–
32], awaits future investigation.
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